Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Reder

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
The Lancet. Neurology|July 9, 2010
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosisChris H Polman, Antonio Bertolotto, Florian Deisenhammer, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Relapses in multiple sclerosis: Relationship to disabilityDouglas S Goodin, Anthony T Reder, Robert A Bermel, et al.
Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.
Journal of Neurology|May 2, 2022
Proposal of new diagnostic criteria for fatal familial insomniaMin Chu, Kexin Xie, Jing Zhang, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Annals of Neurology|December 23, 2011
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility lociNikolaos A Patsopoulos, , , et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Lancet. Neurology|July 9, 2010
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosisChris H Polman, Antonio Bertolotto, Florian Deisenhammer, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Relapses in multiple sclerosis: Relationship to disabilityDouglas S Goodin, Anthony T Reder, Robert A Bermel, et al.
Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.
Journal of Neurology|May 2, 2022
Proposal of new diagnostic criteria for fatal familial insomniaMin Chu, Kexin Xie, Jing Zhang, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Annals of Neurology|December 23, 2011
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility lociNikolaos A Patsopoulos, , , et al.
Pageof 9